MINOMIC
MiCheck® is a blood test that uses their patented monoclonal antibody together with other biomarkers to estimate the risk of a patient having aggressive prostate cancer. The MiCheck® test is designed to assist urologists in making the decision to recommend a patient has a biopsy or moves on to some form of active surveillance monitoring.
MINOMIC
Industry:
Biotechnology Health Care
Founded:
2007-01-01
Address:
Australia, Isabela, Philippines
Country:
Philippines
Website Url:
http://www.minomic.com
Total Employee:
11+
Status:
Active
Contact:
+61 2 9850 4000
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Airnorth
Airnorth is an unlisted public company .
Biotech
Biotech is a healthcare company.
BVG India
BVG India is an outsourcing company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Geneius
Geneius is a Biotechnology company.
Guardian Fall
Guardian Fall is a human safety product company.
Kainos Medicine
Kainos Medicine is a clinical-stage company.
Wellmarker Bio
Wellmarker Bio Co., Ltd. is the first spin off company.
Current Employees Featured
Official Site Inspections
http://www.minomic.com
- Host name: 655191.cloudwaysapps.com
- IP address: 128.199.234.225
- Location: Singapore
- Latitude: 1.314
- Longitude: 103.6839
- Timezone: Asia/Singapore
- Postal: 62
More informations about "Minomic"
Home - We are Minomic
Learn More Clinically significant prostate cancer risk score Minomic We are an Australian company specialising in the commercialisation of tests for solid tumors in cancers such as …See details»
Company - We are Minomic
Minomic is an immuno-oncology research company – developer of prostate cancer diagnostics. Learn how we target tumors for imaging of cancers.See details»
Management - We are Minomic
Minomic has a management team with deep experience developing and commercialising diagnostic assays for cancer detection.See details»
Minomic - Crunchbase Company Profile & Funding
Minomic is an unlisted public company. View contacts for Minomic to access new leads and connect with decision-makers. MiCheck® is a blood test that uses their patented monoclonal …See details»
Minomic International Ltd - MTPConnect
Minomic International Ltd is an Australian immuno-oncology company that has developed an in vitro diagnostic test for the detection of prostate cancer called MiCheck®. In clinical studies, …See details»
Minomic - Macquarie University
Minomic is making waves globally with their groundbreaking innovation. With strong collaborations with universities, research institutes, and companies, Minomic boasts a wealth of expertise in …See details»
Minomic Company Profile - Office Locations, Competitors ... - Craft
Minomic is an immuno-oncology company that has developed an in vitro diagnostic test for the early detection of prostate cancer. It offers MiCheck, prostate is intended for use as an aid to …See details»
Minomic Company Profile 2024: Valuation, Funding
Minomic is headquartered in Macquarie Park, Australia. What is the size of Minomic? Minomic has 14 total employees. What industry is Minomic in? Minomic’s primary industry is Biotechnology. Is Minomic a private or public …See details»
MiCheck® Prostate - We are Minomic
MiCheck® Prostate is a cancer blood test: quick, non-invasive, highly specific. Why is MiCheck® Prostate the missing step in cancer diagnosis?See details»
Minomic International Ltd - ADVANCED …
Minomic International Ltd is an Australian diagnostic company specialising in development of diagnostics for solid tumours, including prostate, bladder and pancreas. Minomic has developed the in vitro diagnostic MiCheck® Prostate …See details»
Minomic International Ltd - VentureRadar
Website: http://www.minomic.com/ Minomic International Limited commercialises late stage biotechnology development projects. The first two diagnostic products for the detection of …See details»
Minomic - Products, Competitors, Financials, Employees, …
Minomic focuses on the development of diagnostic tests for solid tumors, particularly in the oncology domain. The company's flagship product is an in vitro diagnostic test called MiCheck …See details»
8. Minomic - AusBiotech Ltd
Sydney-based immuno-oncology company, Minomic International Ltd, was jointly awarded a prestigious Australian science prize recognising ‘outstanding’ science that uses its patented …See details»
Minomic - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 · Minomic uses 14 technology products and services including HTML5, Google Maps API, and Disqus, according to G2 Stack. Minomic is actively using 30 technologies for its …See details»
Contact Us - We are Minomic
Would you like to talk with Minomic about: Partnering with us to take our products to your markets? Media or upcoming events? Some feedback that you have? Address Level 1, 3 …See details»
Minomic - Contacts, Employees, Board Members, Advisors & Alumni
Minomic has 1 current employee profile, CEO and Founder Brad Walsh. Minomic is an unlisted public company.See details»
Australian Diagnostic Firm Minomic Steps Into US With Prostate
Oct 31, 2022 · NEW YORK – With its risk stratification blood test for prostate cancer in hand, Australian diagnostic company Minomic is targeting the US market in its ongoing commercial …See details»
Board - We are Minomic
Minomic board of knowledgeable and experienced managers is represented by Dr Brad Walsh and Mr Raymore MillardSee details»
Minomic Announces Completion of Demerger of GlyTherix Ltd
Sep 25, 2018 · Minomic announces the completion of de-merger of GlyTherix Ltd which is called upon to clear the path for company capital raising. The demerger follows deep consultation …See details»
News and Publications - We are Minomic
May 17, 2024 · Keep up to date with Minomic's company news, clinical study updates, clinical trials, and future launches of MiCheck tests.See details»